Accuracy of urine NGAL commercial assays in critically ill patients.
about
The elusive task of biomarkers of renal injury.Neutrophil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective.The nature and discriminatory value of urinary neutrophil gelatinase-associated lipocalin in critically ill patients at risk of acute kidney injury.Critical research on biomarkers: what's new?NGAL and AKI: the end of a myth?Biomarkers for AKI improve clinical practice: yes
P2860
Accuracy of urine NGAL commercial assays in critically ill patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Accuracy of urine NGAL commercial assays in critically ill patients.
@en
Accuracy of urine NGAL commercial assays in critically ill patients.
@nl
type
label
Accuracy of urine NGAL commercial assays in critically ill patients.
@en
Accuracy of urine NGAL commercial assays in critically ill patients.
@nl
prefLabel
Accuracy of urine NGAL commercial assays in critically ill patients.
@en
Accuracy of urine NGAL commercial assays in critically ill patients.
@nl
P2093
P2860
P1476
Accuracy of urine NGAL commercial assays in critically ill patients.
@en
P2093
Didier Payen
Jean-Marie Launay
Joaquim Mateo
Juliana Henao
Matthieu Legrand
Veronique Giraudeaux
P2860
P2888
P304
P356
10.1007/S00134-012-2788-5
P577
2012-12-15T00:00:00Z